November 20,2007
Grassley, Baucus seek information from former drug company executive in Avandia case
WASHINGTON — Sens. Chuck Grassley and Max Baucus have asked a former drug company research executive to provide information to the Senate Committee on Finance about attempts to intimidate a prominent independent scientist who voiced concerns about drug safety.
Dr. Tadataka Yamada was formerly the head of research at GlaxoSmithKline. He now heads the Global Health Program at the Bill and Melinda Gates Foundation. Dr. John Buse was a professor of medicine at the University of North Carolina in 1999, when he expressed concerns about the diabetes drug Avandia, which is made by GlaxoSmithKline.
###
Next Article Previous Article
Recent News
- As Trump Sits on Key Epstein Files, Wyden Lays Out “Follow the Money” Investigation for DOJ
- Across the Country, Health Insurance Premiums Set to Spike Thanks to Trumpcare
- Wyden Statement on HHS and Treasury Department Nominees at Finance Committee Hearing
- Ahead of committee vote, Wyden opposes Treasury and USTR nominees
- Bipartisan Delegation Urges De-Escalation of US-Canada Trade Conflict In Meeting with Canadian Prime Minister Carney